ECOG-ACRIN Cancer Research Group clinical trial pipeline

8 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 6 with minor changes only.

1. Notable

   Less Invasive Procedures With the Current Standard of Care…Less Invasive Procedures With the Current Standard of Care · Early-Stage Melanoma

   Primary endpoint(s) modified

   Also in this update: Sponsor changed: Eastern Cooperative Oncology Group to ECOG-ACRIN Cancer Research Group; Recruitment opened

   ECOG-ACRIN Cancer Research Group·Phase 3· NCT07068074· Registry history of NCT07068074 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

2. Notable

   Financial Burden Assessment · Stage I-III Colon or Rectal Cancer…Financial Burden Assessment · Stage I-III Colon or Rectal Cancer Undergoing Treatment

   Primary completion moved earlier from Dec 31, 2023 to Oct 13, 2021

   ECOG-ACRIN Cancer Research Group·Not specified· NCT03516942· Registry history of NCT03516942 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.